“…7,8 Inclusion criteria for this substudy were thin-slice NCCT and CTA (<2.5 mm) performed on the same scanner within 30 minutes. Clinical outcome such as modified Rankin Scale (mRS), modified Arterial Occlusive Lesion (mAOL) score, Thrombolysis in Cerebral Infarction perfusion scale (TICI) score, and final infarct volume (FIV), 9 and baseline clinical characteristics (such as age, sex, National Institutes of Health Stroke Scale [NIHSS] score, time from onset to intravenous [IV] recombinant tissue-type plasminogen activator [r-tPA] treatment, time from onset to groin puncture, occlusion site, and atrial fibrillation) were collected during the execution of the trial. Of 248 consecutive patients with thin-slice NCCT and CTA, 10 were excluded because the time between NCCT and CTA imaging exceeded 30 minutes, 3 because CTA was performed before NCCT imaging, 3 because CTA and NCCT were performed on a different scanner, 39 because of imaging quality limitations, including movement artifacts (25), noisy NCCT image (10), incomplete region of interest (3), and CTA triggered too early or too late (1).…”